findmyKOL
Clinical trialNCT02319187UnknownPhase 3Interventional

Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial

SponsorChinese Academy of Medical SciencesEnrollment240Esophageal Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Binghe Xu, M.D.

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    Study Chair
  • Jing Huang

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Hebei Four Hospital

    Shijiazhuang, Hebei, China

    Recruiting
  • the First Affiliated Hospital of Xinxiang Medical College

    Xinxiang, Henan, China

    Recruiting
  • the First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

    Recruiting
  • Tongji Hospital, Tongji Medical College

    Wuhan, Hubei, China

    Recruiting
  • Mongolia Chifeng Hospital

    Chifeng, Inner Mongolia, China

    Recruiting
  • Ordos Central Hospital

    Ordos, Inner Mongolia, China

    Recruiting
  • Jiangsu Taizhou Peoples Hospital

    Taizhou, Jiangsu, China

    Recruiting
  • Qinghai Cancer Hosptal

    Xining, Qinghai, China

    Recruiting
  • Shanxi Province Cancer Hospital

    Taiyuan, Shanxi, China

    Recruiting
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    Beijing, China

    Binghe Xu, M.D.Jing Huang, M.D.
    Recruiting
  • Hunan Cancer Hospital,the Affiliated Cancer Hospital of Xianya School of Medicine

    Changsha, China

    Lin Wu, MD
    Recruiting
  • Herbin Medical University Cancer Hospital

    Herbin, China

    Yuxian Bai, MD
    Recruiting
  • Henan Cancer Hospital

    Zhengzhou, China

    Ying Liu, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2014
Primary completion
31 Dec 2016
Completion
30 Jun 2017
Last update posted
3 Aug 2015
Registered enrollment
240
Registry id
NCT02319187

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.